Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Untch, Michael"" wg kryterium: Autor


Tytuł:
Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study.
Autorzy:
Reinisch, Mattea
Untch, Michael
Mahlberg, Rolf
Reimer, Toralf
Hitschold, Thomas
Marmé, Frederik
Aydogdu, Mustafa
Schmatloch, Sabine
Lück, Hans-Joachim
Schmidt, Marcus
Ladda, Ekkehart
Sinn, Bruno Valentin
Klare, Peter
Janni, Wolfgang
Jackisch, Christian
Denkert, Carsten
Seiler, Sabine
Göhler, Thomas
Michel, Laura
Burchardi, Nicole
Pokaż więcej
Temat:
HER2 positive breast cancer
SUBCUTANEOUS injections
ABDOMINAL wall
PATIENT preferences
TRASTUZUMAB
Źródło:
Breast; Dec2022, Vol. 66, p110-117, 8p
Czasopismo naukowe
Tytuł:
Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy.
Autorzy:
Krug, David
Vladimirova, Valentina
Untch, Michael
Kühn, Thorsten
Schneeweiss, Andreas
Denkert, Carsten
Ataseven, Beyhan
Solbach, Christine
Gerber, Bernd
Tesch, Hans
Golatta, Michael
Seiler, Sabine
Heil, Jörg
Nekljudova, Valentina
Holtschmidt, Johannes
Loibl, Sibylle
Pokaż więcej
Źródło:
Breast; Apr2024, Vol. 74, pN.PAG-N.PAG, 1p
Czasopismo naukowe
Tytuł:
Disease-free survival as a surrogate for overall survival in HR+/HER2– early breast cancer: A correlation analysis.
Autorzy:
Untch, Michael (AUTHOR) michael.untch@helios-gesundheit.de
Pérol, David (AUTHOR)
Mayer, Erica L. (AUTHOR)
Cortes, Javier (AUTHOR)
Nusch, Arnd (AUTHOR)
Cameron, David (AUTHOR)
Barrios, Carlos (AUTHOR)
Delea, Thomas (AUTHOR)
Danyliv, Andrii (AUTHOR)
Mishra, Namita (AUTHOR)
Gupta, Rhea (AUTHOR)
Pathak, Purnima (AUTHOR)
Fasching, Peter A. (AUTHOR)
Pokaż więcej
Źródło:
European Journal of Cancer. May2024, Vol. 202, pN.PAG-N.PAG. 1p.
Czasopismo naukowe
Tytuł:
Statistical modelling of HER2-positivity in breast cancer: Final analyses from two large, multicentre, non-interventional studies in Germany.
Autorzy:
Rüschoff, Josef
Lebeau, Annette
Sinn, Peter
Schildhaus, Hans-Ulrich
Decker, Thomas
Ammann, Johannes
Künzel, Claudia
Koch, Winfried
Untch, Michael
Pokaż więcej
Temat:
BREAST cancer
STATISTICAL models
PROGESTERONE receptors
HORMONE receptors
PATIENT selection
Źródło:
Breast; Feb2020, Vol. 49, p246-253, 8p
Terminy geograficzne:
GERMANY
Czasopismo naukowe
Tytuł:
Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial.
Autorzy:
Golshan, Mehra
Wong, Stephanie M.
Loibl, Sibylle
Huober, Jens Bodo
O'Shaughnessy, Joyce
Rugo, Hope S.
Wolmark, Norman
Ansell, Peter
Maag, David
Sullivan, Danielle M.
Metzger-Filho, Otto
Von Minckwitz, Gunter
Geyer, Charles E.
Sikov, William M.
Untch, Michael
Pokaż więcej
Temat:
TRIPLE-negative breast cancer
CANCER chemotherapy
MAGNETIC resonance imaging
MAGNETIC resonance mammography
MAGNETIC resonance imaging of cancer
LUMPECTOMY
Źródło:
European Journal of Surgical Oncology; Feb2020, Vol. 46 Issue 2, p223-228, 6p
Czasopismo naukowe
Tytuł:
Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials.
Autorzy:
Gustavo Werutsky, G. (AUTHOR)
Untch, Michael (AUTHOR)
Hanusch, Claus (AUTHOR)
Fasching, Peter A. (AUTHOR)
Blohmer, Jens-Uwe (AUTHOR)
Seiler, Sabine (AUTHOR)
Denkert, Carsten (AUTHOR)
Tesch, Hans (AUTHOR)
Jackisch, Christian (AUTHOR)
Gerber, Bernd (AUTHOR)
Schneeweiss, Andreas (AUTHOR)
Link, Theresa (AUTHOR)
Krug, David (AUTHOR)
Huober, Jens (AUTHOR)
Rhiem, Kerstin (AUTHOR)
Kühn, Thorsten (AUTHOR)
Vladimirova, Valentina (AUTHOR)
Nekljudova, Valentina (AUTHOR)
Loibl, Sibylle (AUTHOR)
Pokaż więcej
Źródło:
European Journal of Cancer. May2020, Vol. 130, p92-101. 10p.
Czasopismo naukowe
Tytuł:
Pembrolizumab vs placebo + chemotherapy as neoadjuvant treatment, followed by pembrolizumab vs placebo as adjuvant treatment for early triple-negative breast cancer (TNBC): Phase 3 KEYNOTE-522 study.
Autorzy:
Kümmel, Sherko
Cortés, Javier
Dent, Rebecca
Pusztai, Lajos
McArthur, Heather
Bergh, Jonas
Denkert, Carsten
Park, Yeon Hee
Hui, Rina
Harbeck, Nadia
Takahashi, Masato
Untch, Michael
Fasching, Peter A.
Cardoso, Fatima
Ding, Yu
Tryfonidis, Konstantinos
Aktan, Gursel
Karantza, Vassiliki
O'Shaughnessy, Joyce
Schmid, Peter
Pokaż więcej
Temat:
TRIPLE-negative breast cancer
NEOADJUVANT chemotherapy
PLACEBOS
PEMBROLIZUMAB
THERAPEUTICS
Źródło:
European Journal of Surgical Oncology; Feb2022, Vol. 48 Issue 2, pe30-e31, 2p
Czasopismo naukowe
Tytuł:
pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy – A retrospective pooled analysis of individual patients data of four German neoadjuvant trials.
Autorzy:
Reinisch, Mattea
Huober, Jens
von Minckwitz, Gunter
Blohmer, Jens-Uwe
Denkert, Carsten
Hanusch, Claus
Jackisch, Christian
Kümmel, Sherko
Schneeweiss, Andreas
Rhiem, Kerstin
Lederer, Bianca
Untch, Michael
Nekljudova V, Valentina
Loibl, Sibylle
Pokaż więcej
Temat:
PATIENTS
BREAST cancer
CLINICAL trials
CANCER chemotherapy
CARCINOMA
Źródło:
Breast; Apr2017, Vol. 32, p73-78, 6p
Czasopismo naukowe
Tytuł:
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial.
Autorzy:
Untch, Michael
Jackisch, Christian
Schneeweiss, Andreas
Conrad, Bettina
Aktas, Bahriye
Denkert, Carsten
Eidtmann, Holger
Wiebringhaus, Hermann
Kümmel, Sherko
Hilfrich, Jörn
Warm, Mathias
Paepke, Stefan
Just, Marianne
Hanusch, Claus
Hackmann, John
Blohmer, Jens-Uwe
Clemens, Michael
Darb-Esfahani, Silvia
Schmitt, Wolfgang Daniel
Dan Costa, Serban
Pokaż więcej
Źródło:
Lancet Oncology. Mar2016, Vol. 17 Issue 3, p345-356. 12p.
Czasopismo naukowe
Tytuł:
Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge.
Autorzy:
Jackisch, Christian
Cortazar, Patricia
Geyer, Charles E.
Gianni, Luca
Gligorov, Joseph
Machackova, Zuzana
Perez, Edith A.
Schneeweiss, Andreas
Tolaney, Sara M.
Untch, Michael
Wardley, Andrew
Piccart, Martine
Geyer, Charles E Jr
Pokaż więcej
Źródło:
Cancer Treatment Reviews; Sep2021, Vol. 99, pN.PAG-N.PAG, 1p
Czasopismo naukowe
Tytuł:
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial
Autorzy:
Untch, Michael
Loibl, Sibylle
Bischoff, Joachim
Eidtmann, Holger
Kaufmann, Manfred
Blohmer, Jens-Uwe
Hilfrich, Jörn
Strumberg, Dirk
Fasching, Peter A
Kreienberg, Rolf
Tesch, Hans
Hanusch, Claus
Gerber, Bernd
Rezai, Mahdi
Jackisch, Christian
Huober, Jens
Kühn, Thorsten
Nekljudova, Valentina
von Minckwitz, Gunter
Pokaż więcej
Źródło:
Lancet Oncology. Feb2012, Vol. 13 Issue 2, p135-144. 10p.
Czasopismo naukowe
Tytuł:
Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study.
Autorzy:
García-Sáenz, José Angel (AUTHOR)
Marmé, Frederik (AUTHOR)
Untch, Michael (AUTHOR)
Bonnefoi, Hervé (AUTHOR)
Kim, Sung-Bae (AUTHOR)
Bear, Harry (AUTHOR)
Mc Carthy, Nicole (AUTHOR)
Gelmon, Karen (AUTHOR)
Martin, Miguel (AUTHOR)
Kelly, Catherine M. (AUTHOR)
Reimer, Toralf (AUTHOR)
Toi, Masakazu (AUTHOR)
Law, Ernest (AUTHOR)
Bhattacharyya, Helen (AUTHOR)
Gnant, Michael (AUTHOR)
Makris, Andreas (AUTHOR)
Seiler, Sabine (AUTHOR)
Burchardi, Nicole (AUTHOR)
Nekljudova, Valentina (AUTHOR)
Loibl, Sibylle (AUTHOR)
Pokaż więcej
Źródło:
European Journal of Cancer. Jan2024, Vol. 196, pN.PAG-N.PAG. 1p.
Czasopismo naukowe
Tytuł:
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041).
Autorzy:
Fasching, Peter A. (AUTHOR)
Hein, Alexander (AUTHOR)
Kolberg, Hans-Christian (AUTHOR)
Häberle, Lothar (AUTHOR)
Uhrig, Sabrina (AUTHOR)
Rübner, Matthias (AUTHOR)
Belleville, Erik (AUTHOR)
Hack, Carolin C. (AUTHOR)
Fehm, Tanja N. (AUTHOR)
Janni, Wolfang (AUTHOR)
Hartmann, Arndt (AUTHOR)
Erber, Ramona (AUTHOR)
Theuser, Anna-Katharin (AUTHOR)
Brucker, Sara Y. (AUTHOR)
Hartkopf, Andreas D. (AUTHOR)
Untch, Michael (AUTHOR)
Pokaż więcej
Źródło:
European Journal of Cancer. May2023, Vol. 184, p1-9. 9p.
Czasopismo naukowe
Tytuł:
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Autorzy:
Loibl, Sibylle
O'Shaughnessy, Joyce
Untch, Michael
Sikov, William M
Rugo, Hope S
McKee, Mark D
Huober, Jens
Golshan, Mehra
von Minckwitz, Gunter
Maag, David
Sullivan, Danielle
Wolmark, Norman
McIntyre, Kristi
Ponce Lorenzo, Jose J
Metzger Filho, Otto
Rastogi, Priya
Symmans, W Fraser
Liu, Xuan
JrGeyer, Charles E
O'Shaughnessy, Joyce
Pokaż więcej
Źródło:
Lancet Oncology. Apr2018, Vol. 19 Issue 4, p497-509. 13p.
Czasopismo naukowe
Tytuł:
Effects of capecitabine as part of neo-/adjuvant chemotherapy – A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients.
Autorzy:
van Mackelenbergh, Marion T. (AUTHOR)
Seither, Fenja (AUTHOR)
Möbus, Volker (AUTHOR)
O'Shaughnessy, Joyce (AUTHOR)
Martin, Miguel (AUTHOR)
Joensuu, Heikki (AUTHOR)
Untch, Michael (AUTHOR)
Nitz, Ulrike (AUTHOR)
Steger, Guenther G. (AUTHOR)
Miralles, Juan J. (AUTHOR)
Barrios, Carlos H. (AUTHOR)
Toi, Masakazu (AUTHOR)
Bear, Harry D. (AUTHOR)
Muss, Hyman (AUTHOR)
Reimer, Toralf (AUTHOR)
Nekljudova, Valentina (AUTHOR)
Loibl, Sibylle (AUTHOR)
Pokaż więcej
Źródło:
European Journal of Cancer. May2022, Vol. 166, p185-201. 17p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies